NCT00576706View on ClinicalTrials.gov

PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity

PHASE3CompletedINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Rheumatoid ArthritisOsteoarthritisAnkylosing Spondylitis
Interventions
DRUG

Rebamipide

Rebamipide 100㎎, 12 weeks

DRUG

Misoprostol

Misoprostol 200㎍ 12 weeks

Trial Locations (10)

Unknown

Bucheon-si

Daegu

Daejeon

Gwangju

Incheon

Jeonju

Jinju

Pusan

Seoul

Suwon

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY